Dr. George S. Mack is an analyst, managing director and founder at BioDecade where he writes proprietary biotech stock research for clients. He also performs interviews with biotech analysts and biotech CEOs for publications, including The Life Sciences Report. Mack has authored for Nature Biotechnology, Nature Medicine and the Journal of the National Cancer Institute. He has been a consulting analyst to Decision Resources, and he has been a major contributor to Buyside Magazine, Wall Street Research and Reuters-Multex where he helped develop products intended for institutional investors. Dr. Mack is a graduate of the University of South Carolina in Columbia and the Medical University of South Carolina in Charleston.